SKF 83959 HYDROBROMIDE manufacturers
- SKF83959
-
- $44.00
-
2026-07-14
- CAS:80751-85-5
- Purity: 99.96%
- Supply Ability: 10g
|
| | SKF 83959 HYDROBROMIDE Basic information |
| Product Name: | SKF 83959 HYDROBROMIDE | | Synonyms: | 6-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-1-(3-METHYLPHENYL)-1H-3-BENZAZEPINE-7,8-DIOL HYDROBROMIDE;6-CHLORO-7,8-DIHYDROXY-3-METHYL-1-(3-METHYLPHENYL)-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE;6-Chloro-2,3,4,5-tetrahydro-3-methyl-1-(3-methylphenyl)-1H-3-benzazepine-7,8-diol;6-Chloro-7,8-dihydroxy-3-methyl-1-(3-methylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide;N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol;1H-3-Benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-3-methyl-1-(3-methylphenyl)-;SKF 83959 hydrobromi;SKF83959, 10 mM in DMSO | | CAS: | 80751-85-5 | | MF: | C18H20ClNO2 | | MW: | 317.81 | | EINECS: | | | Product Categories: | Dopamine receptor | | Mol File: | 80751-85-5.mol |  |
| | SKF 83959 HYDROBROMIDE Chemical Properties |
| storage temp. | Store at RT | | solubility | DMSO: 26 mg/mL, soluble | | form | solid | | color | white | | InChI | 1S/C18H20ClNO2.BrH/c1-11-4-3-5-12(8-11)15-10-20(2)7-6-13-14(15)9-16(21)18(22)17(13)19;/h3-5,8-9,15,21-22H,6-7,10H2,1-2H3;1H | | InChIKey | FHYWNBUFNGHNCP-UHFFFAOYSA-N | | SMILES | Br[H].CN1CCc2c(Cl)c(O)c(O)cc2C(C1)c3cccc(C)c3 |
| Safety Statements | 22-24/25 | | WGK Germany | 3 | | Storage Class | 11 - Combustible Solids |
| | SKF 83959 HYDROBROMIDE Usage And Synthesis |
| Uses | SKF-83959 was used in dopamine signaling studies on eye blinking in monkeys and on phosphorylation of CaMKIIα in mice. | | Definition | ChEBI: A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a 3-methylphenyl substituent at position 1, a methyl substituent at position 3, a chloro substituent at position 6 and two hydroxy substituents at positions 7 and 8. Dopamine D1-like receptor p
rtial agonist (Ki values are 1.18, 7.56, 920 and 399 nM for rat D1, D5, D2 and D3 receptors respectively). May act as an antagonist in vivo, producing anti-Parkinsonian effects and antagonising the behavioral effects of cocaine. | | Biological Activity | Dopamine D 1 -like receptor partial agonist (K i values are 1.18, 7.56, 920 and 399 nM for rat D 1 , D 5 , D 2 and D 3 receptors respectively). May act as an antagonist in vivo , producing antiparkinsonian effects and antagonizing the behavioral effects of cocaine. | | in vivo | SKF83959 (0.5 and 1 mg/kg; i.p.; 1 hour) reverses the scopolamine-induced cognitive impairments in the passive avoidance task and Y-Maze test[1].
SKF83959 (1 mg/kg; i.p.; 30 minutes) induced memory enhancing effects are prevented by brain-derived neurotrophic factor system blockade[1].
SKF83959 has anti-amnesic activities and restores the scopolamine-decreased BDNF signaling pathway in the hippocampus in mice[1]. | Animal Model: | Male ICR male mice (8 weeks)[1] | | Dosage: | 0.5 and 1 mg/kg | | Administration: | I.p.; 1 hour | | Result: | Reversed the scopolamine-induced cognitive impairments in the passive avoidance task and Y-Maze test.
|
| Animal Model: | Male ICR male mice (8 weeks)[1] | | Dosage: | 1 mg/kg | | Administration: | I.p.; 30 minutes | | Result: | The memory enhancing effects were prevented by BDNF system blockade.
|
| | IC 50 | D1 Receptor: 1.18 nM (Ki); Sigma 1 Receptor; D5 Receptor: 7.56 nM (Ki); D2 Receptor: 920 nM (Ki); D3 Receptor: 399 nM (Ki) |
| | SKF 83959 HYDROBROMIDE Preparation Products And Raw materials |
|